SureTrader Stock Hero Advertisement SureTrader SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Benitec Biopharma Ltd. ADR (BTEBY)

BTEBY RSS Feed
Add BTEBY Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Wildbilly, Blane
Search This Board:
Last Post: 5/21/2015 6:47:07 PM - Followers: 40 - Board type: Free - Posts Today: 0
Silencing Genes For Life™





 
                                                                                                                                                    

HOME PAGE
                           



 
 
 
 
 
 
ddRNAi: expressed RNA interference technology
ddRNAi (DNA-directed RNAi) is a unique platform technology for silencing unwanted or disease-causing genes. In the context of therapy, ddRNAi avoids many of the drawbacks of other gene silencing technologies and produces much longer-lasting effects. Benitec Biopharma pioneered ddRNAi and was the first company to demonstrate expressed RNAi in human cells. We hold a dominant intellectual property position in RNAi, with over 40 issued global patents for the human use of ddRNAi. Learn how ddRNAi could target countless human and viral genes. Track our pipeline programs using this exciting technology. View the scope of our patents in ddRNAi. Join us in developing transformational solutions for human health.

Pipeline for ddRNAi gene silencing

Benitec Biopharma’s pipeline of in-house and partnered programs to develop therapeutics for chronic and life-threatening conditions is based on our proprietary technology, DNA-directed RNA(ddRNAi). View our out-licensed programs  

Due to its demonstrated ability to effect long-lasting gene silencing, once proven in human trials, ddRNAi technology has significant potential to treat or cure a broad range of human diseases and conditions. These include cancers, neurological diseases, infectious diseases, autoimmune diseases, genetic diseases and other afflictions that are associated with the expression of a small number of key genes.



Our in-house pipeline is summarized below,  In-house pipeline

 

. View our out-licensed programs  Out-licensed programs Successful development of therapeutic products in just one of these programs would be a major breakthrough in medical therapy.


 


 

 





 

Expressed RNAi for lasting treatment or cure

Tacere Therapeutics develops human therapeutics based on RNA interference (RNAi)  and ddRNAi gene-silencing technology from Benitec Biopharma. Using this approach, the drugs we create promise long term treatment or cure with a single dose.

We target human diseases for which there is currently no effective treatment.  Our pipeline includes drugs for Hepatitis C and Age-Related Macular Degeneration.

Tacere Therapeutics is a Benitec Biopharma company.


http://www.tacerebio.com/index.htm
 


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BTEBY
Current Price
Volume:
Bid Ask Day's Range
Wiki
PostSubject
#1747  Sticky Note 29 April 2015 georgejjl 04/28/15 09:21:07 PM
#1713  Sticky Note Benitec Due Diligence - As of April 8,2015 Blane 04/09/15 12:45:58 AM
#1779   Yep Yep. It boggles my mind that this Blane 05/21/15 06:47:07 PM
#1778   Thanks Blane! I can feel the tension and inapnchpenny 05/21/15 05:51:13 PM
#1777   Money once again glowing back into gene therapy! Blane 05/21/15 02:48:12 PM
#1776   Dr. Claudia Kloth PhD georgejjl 05/20/15 08:41:26 PM
#1775   I suggest that everyone take a look at georgejjl 05/20/15 08:25:33 PM
#1774   Panno speaks on latest Company Presentation. http://seekingalpha.com/instablog/1 Blane 05/20/15 11:22:33 AM
#1773   The latest from BENITEC georgejjl 05/19/15 08:20:52 PM
#1772   Regarding the discussions on Hotcopper concerning the TT-034 trial georgejjl 05/16/15 02:50:42 PM
#1771   CALIMMUNE http://www.nature.com/mtna/journal/v4/n4/full/mtna201510a.html G georgejjl 05/14/15 11:14:43 PM
#1770   Senator asks VA to break Gilead's patent on Blane 05/13/15 01:11:47 AM
#1769   Great gene therapy payment article. http://www.xconomy.com/national/2014/01/27/g Blane 05/06/15 03:18:13 PM
#1768   Panno's latest. http://seekingalpha.com/author/pannobhaso/instablog Blane 05/04/15 10:33:17 AM
#1767   A lot more besides me are bidding 4 dollars. inapnchpenny 05/04/15 08:55:08 AM
#1766   What I would hate would be for it Blane 05/03/15 11:20:15 PM
#1765   Per Dr. David Suhy: georgejjl 05/03/15 09:04:29 PM
#1764   ASX ANNOUNCEMENT georgejjl 05/03/15 08:01:25 PM
#1763   It would be great if Gilead would throw RCH68 05/03/15 07:13:19 PM
#1762   Here is a post from RSTICKLE on Hotcopper. Blane 05/03/15 03:21:14 PM
#1761   Expect efficacy at the current cohort 3 dose level georgejjl 05/02/15 11:02:18 AM
#1760   Even though I disagree with using low dose inapnchpenny 04/30/15 07:57:57 AM
#1759   There are on average approximately 1.9 times 10 georgejjl 04/29/15 11:52:38 PM
#1758   Inapnchpenny: Respectively check your facts. Read the latest presentation georgejjl 04/29/15 10:09:58 PM
#1757   We are transfecting a percentage of all cells, inapnchpenny 04/29/15 09:17:39 PM
#1756   I agree with you MakeittoV221 04/29/15 09:14:07 PM
#1755   For the science to work like that, 100 inapnchpenny 04/29/15 08:43:32 PM
#1754   I agree. Anyone who wants a piece of Blane 04/29/15 08:20:49 PM
#1753   This one is way undervalued. Don't under estimate MakeittoV221 04/29/15 05:35:39 PM
#1752   Panos latest on TT-034 Blane 04/29/15 02:45:57 PM
#1751   Benitec using "Liver on a chip" to test Blane 04/29/15 10:31:37 AM
#1750   Hoyland was completely wrong in this case georgejjl 04/29/15 12:22:40 AM
#1749   Expect a 15% to 35% reduction in hepatitis georgejjl 04/28/15 10:28:33 PM
#1748   29 April 2015 georgejjl 04/28/15 09:32:24 PM
#1747   29 April 2015 georgejjl 04/28/15 09:21:07 PM
#1746   Wednesday 29 April 2015 georgejjl 04/27/15 07:49:16 PM
#1745   Not from me. I'm the same poster on inapnchpenny 04/23/15 07:59:40 PM
#1744   Nice! Hopefully news on next dosing is Blane 04/23/15 11:44:09 AM
#1743   That's my 100 shares for 3.24 inapnchpenny 04/23/15 11:42:39 AM
#1742   Yeah, but I love Benetech's motto: Technology serving Blane 04/19/15 11:56:19 PM
#1741   Do NOT confuse Benitec with Benitech.org georgejjl 04/19/15 11:46:04 PM
#1740   HCV clinical trial landscape. Posted by Hoyland Blane 04/17/15 08:38:53 PM
#1739   Thanks Bilky! Was mobile, and the header Blane 04/16/15 08:42:27 PM
#1738   BENITEC EXECUTES LICENSE WITH ASKLEPIOS BIOPHARMACEUTICAL Wildbilly 04/16/15 08:17:51 PM
#1737   http://www.businesswire.com/news/home/20150416005563/en/Asklepios-Executes-Licen Blane 04/16/15 04:07:07 PM
#1736   Correction - 100 @ 3.23 inapnchpenny 04/16/15 11:22:47 AM
#1735   .825 x .78 x 5 = 3.21 No arbitrage. Accumulate. inapnchpenny 04/16/15 09:40:56 AM
#1734   100 @ 2.23 inapnchpenny 04/16/15 09:36:12 AM
#1733   Exactly. I think ddrnai is the best chance inapnchpenny 04/16/15 01:10:29 AM
#1732   Great article detailing the history of HCV and Blane 04/16/15 12:26:22 AM
#1731   The first 50 shares at 3.36 is mine inapnchpenny 04/15/15 09:55:06 AM
#1730   Regarding Benitec's licensee Calimmune georgejjl 04/14/15 11:06:30 PM
PostSubject